Abiomed, Inc. Employee Directory
Pharmaceutical ManufacturingUnited States201-500 Employees
Abiomed, Inc. is a United States–based, publicly traded company operating in the pharmaceutical manufacturing sector. It focuses on discovering drugs targeting HIV, HBV, and HCV. The organization is described as employing a few hundred people and maintains its website at idenix.com. The news items reference patent litigation related to hepatitis C therapies and note that Merck acquired Idenix in 2014, illustrating the patent and M&A dynamics within this space. This context underscores the competitive landscape of antiviral drug development in which the company operates.